FDA denies Rigel's COVID-19 hopeful Tavalisse for hospitalized patients, asks for late-stage data

FDA denies Rigel's COVID-19 hopeful Tavalisse for hospitalized patients, asks for late-stage data

Submitted by admin on August 13, 2021 - 10:57am
Source: 
Fierce Pharma
News Tags: 
Rigel Pharmaceuticals
Tavalisse
COVID-19
FDA
Headline: 
FDA denies Rigel's COVID-19 hopeful Tavalisse for hospitalized patients, asks for late-stage data
snippet: 

The FDA has authorized a few of drugs for emergency use in hospitalized COVID-19 patients, but Rigel Pharmaceuticals’ autoimmune disease drug Tavalisse won’t be joining the group right now.

Do Not Allow Advertisers to Use My Personal information